Cargando…

Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial

INTRODUCTION: This study evaluated the secondary effectiveness outcomes for Quit Genius, a digital clinician-assisted cognitive behavioral therapy (CBT) intervention for smoking cessation. METHODS: Adult smokers (N = 556) were randomly assigned to Quit Genius (n = 277), a digital, clinician-assisted...

Descripción completa

Detalles Bibliográficos
Autores principales: Webb, Jamie, Peerbux, Sarrah, Ang, Alfonso, Siddiqui, Sarim, Sherwani, Yusuf, Ahmed, Maroof, MacRae, Hannah, Puri, Hannah, Majeed, Azeem, Glasner, Suzette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597001/
https://www.ncbi.nlm.nih.gov/pubmed/35470860
http://dx.doi.org/10.1093/ntr/ntac113
_version_ 1784815994952220672
author Webb, Jamie
Peerbux, Sarrah
Ang, Alfonso
Siddiqui, Sarim
Sherwani, Yusuf
Ahmed, Maroof
MacRae, Hannah
Puri, Hannah
Majeed, Azeem
Glasner, Suzette
author_facet Webb, Jamie
Peerbux, Sarrah
Ang, Alfonso
Siddiqui, Sarim
Sherwani, Yusuf
Ahmed, Maroof
MacRae, Hannah
Puri, Hannah
Majeed, Azeem
Glasner, Suzette
author_sort Webb, Jamie
collection PubMed
description INTRODUCTION: This study evaluated the secondary effectiveness outcomes for Quit Genius, a digital clinician-assisted cognitive behavioral therapy (CBT) intervention for smoking cessation. METHODS: Adult smokers (N = 556) were randomly assigned to Quit Genius (n = 277), a digital, clinician-assisted CBT intervention or very brief advice (VBA) to stop smoking, an evidence-based, 30-s intervention designed to facilitate quit attempts, coupled with referral to a cessation service (n = 279). Participants were offered combination nicotine replacement therapy (patches and gum) tailored to individual nicotine dependence. Analyses (n = 530), by intention-to-treat, compared Quit Genius and VBA at 4, 26, and 52 weeks post-quit date (QD). The primary outcome was self-reported 7-day point prevalence abstinence (PPA) at 4 weeks post-QD. Consecutive 7-day point-prevalence abstinence, defined as abstinent at two or more consecutive timepoints, was examined at weeks 26 and 52 to indicate long-term effectiveness. Abstinence was verified using a random sample of participants with carbon monoxide breath testing of <5 parts per million (n = 280). RESULTS: Self-reported consecutive 7-day PPA at weeks 26 and 52 for Quit Genius was 27.2% and 22.6%, respectively, compared with VBA which was 16.6% and 13.2% (RR = 1.70, 95% CI, 1.22-2.37; p = .003, 26 weeks; RR = 1.71, 95% CI, 1.17–2.50; P = .005, 52 weeks). Biochemically verified abstinence was significantly different at 26- (p = .03) but not 52 weeks (p = .16). Quit Genius participants were more likely to remain abstinent than those who received VBA (RR = 1.71, 95% CI 1.17–2.50; p = .005). CONCLUSIONS: This study provides secondary evidence for the long-term effectiveness of Quit Genius in comparison with VBA. Future trials of digital interventions without clinician support and comparisons with active treatment are needed. IMPLICATIONS: The long-term effectiveness of clinician-assisted digital smoking cessation interventions has not been well studied. This study established the long-term effectiveness of an extended CBT-based intervention; results may inform implementation of scalable approaches to smoking cessation in the health system.
format Online
Article
Text
id pubmed-9597001
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95970012022-10-31 Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial Webb, Jamie Peerbux, Sarrah Ang, Alfonso Siddiqui, Sarim Sherwani, Yusuf Ahmed, Maroof MacRae, Hannah Puri, Hannah Majeed, Azeem Glasner, Suzette Nicotine Tob Res Original Investigations INTRODUCTION: This study evaluated the secondary effectiveness outcomes for Quit Genius, a digital clinician-assisted cognitive behavioral therapy (CBT) intervention for smoking cessation. METHODS: Adult smokers (N = 556) were randomly assigned to Quit Genius (n = 277), a digital, clinician-assisted CBT intervention or very brief advice (VBA) to stop smoking, an evidence-based, 30-s intervention designed to facilitate quit attempts, coupled with referral to a cessation service (n = 279). Participants were offered combination nicotine replacement therapy (patches and gum) tailored to individual nicotine dependence. Analyses (n = 530), by intention-to-treat, compared Quit Genius and VBA at 4, 26, and 52 weeks post-quit date (QD). The primary outcome was self-reported 7-day point prevalence abstinence (PPA) at 4 weeks post-QD. Consecutive 7-day point-prevalence abstinence, defined as abstinent at two or more consecutive timepoints, was examined at weeks 26 and 52 to indicate long-term effectiveness. Abstinence was verified using a random sample of participants with carbon monoxide breath testing of <5 parts per million (n = 280). RESULTS: Self-reported consecutive 7-day PPA at weeks 26 and 52 for Quit Genius was 27.2% and 22.6%, respectively, compared with VBA which was 16.6% and 13.2% (RR = 1.70, 95% CI, 1.22-2.37; p = .003, 26 weeks; RR = 1.71, 95% CI, 1.17–2.50; P = .005, 52 weeks). Biochemically verified abstinence was significantly different at 26- (p = .03) but not 52 weeks (p = .16). Quit Genius participants were more likely to remain abstinent than those who received VBA (RR = 1.71, 95% CI 1.17–2.50; p = .005). CONCLUSIONS: This study provides secondary evidence for the long-term effectiveness of Quit Genius in comparison with VBA. Future trials of digital interventions without clinician support and comparisons with active treatment are needed. IMPLICATIONS: The long-term effectiveness of clinician-assisted digital smoking cessation interventions has not been well studied. This study established the long-term effectiveness of an extended CBT-based intervention; results may inform implementation of scalable approaches to smoking cessation in the health system. Oxford University Press 2022-04-26 /pmc/articles/PMC9597001/ /pubmed/35470860 http://dx.doi.org/10.1093/ntr/ntac113 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigations
Webb, Jamie
Peerbux, Sarrah
Ang, Alfonso
Siddiqui, Sarim
Sherwani, Yusuf
Ahmed, Maroof
MacRae, Hannah
Puri, Hannah
Majeed, Azeem
Glasner, Suzette
Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial
title Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial
title_full Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial
title_fullStr Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial
title_full_unstemmed Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial
title_short Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial
title_sort long-term effectiveness of a clinician-assisted digital cognitive behavioral therapy intervention for smoking cessation: secondary outcomes from a randomized controlled trial
topic Original Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597001/
https://www.ncbi.nlm.nih.gov/pubmed/35470860
http://dx.doi.org/10.1093/ntr/ntac113
work_keys_str_mv AT webbjamie longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT peerbuxsarrah longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT angalfonso longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT siddiquisarim longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT sherwaniyusuf longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT ahmedmaroof longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT macraehannah longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT purihannah longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT majeedazeem longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial
AT glasnersuzette longtermeffectivenessofaclinicianassisteddigitalcognitivebehavioraltherapyinterventionforsmokingcessationsecondaryoutcomesfromarandomizedcontrolledtrial